JPMorgan Chase & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1K | Sell |
|
|||||
|
2025
Q1 | $334K | Sell |
|
|||||
|
2024
Q4 | $1.1M | Buy |
|
|||||
|
2024
Q3 | $1.19M | Buy |
|
|||||
|
2024
Q2 | $381K | Buy |
|
|||||
|
2024
Q1 | $589 | Hold |
|
|||||
|
2023
Q4 | $357 | Sell |
|
|||||
|
2023
Q3 | $21.9K | Buy |
|
|||||
|
2023
Q2 | $4.09K | Sell |
|
|||||
|
2023
Q1 | $163K | Buy |
|
|||||
|
2022
Q4 | $433K | Sell |
|
|||||
|
2022
Q3 | $738K | Sell |
|
|||||
|
2022
Q2 | $2.53M | Buy |
|
|||||
|
2022
Q1 | $985K | Buy |
|
|||||
|
2021
Q4 | $935K | Sell |
|
|||||
|
2021
Q3 | $4.19M | Sell |
|
|||||
|
2021
Q2 | $4.03M | Buy |
|
|||||
|
2021
Q1 | $4.5M | Buy |
|
|||||
|
2020
Q4 | $3M | Sell |
|
|||||
|
2020
Q3 | $3.57M | Sell |
|
|||||
|
2020
Q2 | $4.93M | Buy |
|
|||||
|
2020
Q1 | $3.29M | Sell |
|
|||||
|
2019
Q4 | $39.7M | Buy |
|
|||||
|
2019
Q3 | $31.4M | Buy |
|
|||||
|
2019
Q2 | $52.1M | Sell |
|
|||||
|
2019
Q1 | $73.1M | Buy |
|
|||||
|
2018
Q4 | $58M | Buy |
|
|||||
|
2018
Q3 | $98M | Sell |
|
|||||
|
2018
Q2 | $104M | Buy |
|
|||||
|
2018
Q1 | $135M | Sell |
|
|||||
|
2017
Q4 | $95.9M | Sell |
|
|||||
|
2017
Q3 | $55M | Buy |
|
|||||
|
2017
Q2 | $44.1M | Sell |
|
|||||
|
2017
Q1 | $65.9M | Buy |
|
|||||
|
2016
Q4 | $14.5M | Buy |
|
|||||
|
2016
Q3 | $12M | Sell |
|
|||||
|
2016
Q2 | $12.4M | Sell |
|
|||||
|
2016
Q1 | $12.3M | Sell |
|
|||||
|
2015
Q4 | $17.2M | Buy |
|
|||||
|
2015
Q3 | $10.5M | Sell |
|
|||||
|
2015
Q2 | $12.1M | Sell |
|
|||||
|
2015
Q1 | $50M | Sell |
|
|||||
|
2014
Q4 | $75.4M | Buy |
|
|||||
|
2014
Q3 | $53.5M | Buy |
|
|||||
|
2014
Q2 | $56.3M | Sell |
|
|||||
|
2014
Q1 | $55.1M | Buy |
|
|||||
|
2013
Q4 | $20.4M | Sell |
|
|||||
|
2013
Q3 | $20M | Sell |
|
|||||
|
2013
Q2 | $24.6M | Buy |
|